Clinical Trial Update: a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients [Phase 3]

View source ↗

Summary

A multicentre Phase III trial is evaluating risk-based treatment intensification with hyperfractionated radiotherapy in head and neck squamous cell carcinoma an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Lund University Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING